Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | HTR7 | P34969 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | PDE2A | O00408 | 1/20 | 0.46 |
| ▸ | CRHBP | P24387 | 1/20 | 0.46 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.46 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6584608 | 0.93 | FAAH (0.60) | FAAHKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL1331198 | 0.91 | FAAH (0.65) | FAAHHTR1AHTR7DRD4MCHR1 | |
| SCHEMBL17289123 | 0.91 | FAAH (0.65) | FAAHHTR1AHTR7DRD4MCHR1 | |
| SCHEMBL13940592 | 0.86 | HRH3 (0.58) | FAAHHTR1AHTR7DRD4PDE2A | |
| SCHEMBL28824423 | 0.85 | FAAH (0.56) | FAAHHTR1AHTR7DRD4PDE2A | |
| SCHEMBL6583960 | 0.85 | CXCR4 (0.65) | FAAHKDM4EALDH1A1HSD17B10HTR1A | |
| SCHEMBL1331611 | 0.83 | FAAH (0.58) | FAAHKDM4EALDH1A1HTR1AHTR7 | |
| SCHEMBL1331766 | 0.83 | HRH3 (0.63) | FAAHHTR1AHTR7DRD4MCHR1 | |
| SCHEMBL21066574 | 0.83 | CXCR4 (0.65) | FAAHKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL2170401 | 0.83 | CYP3A4 (0.55) | FAAHKDM4EALDH1A1HSD17B10HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105218588-A | A kind of preparation method and application of pyridyl benzoglyoxaline phenylquinoline iridium (III) title complex based on Long carbon chain modification | UNIV NANJING POSTS & TELECOMM | 2016-01-06 | — | — | CN | claimed |
| CN-104910213-A | Phenyl quinoline derivative iridium (III) complex based on piperidine or morpholine methylene substitution, and preparation method and application thereof | UNIV NANJING POSTS & TELECOMM | 2015-09-16 | — | — | CN | claimed |
| US-20250186981-A1 | CATALYST COMPOSITION FOR CYCLIC OLEFIN POLYMERIZATION, AND METHOD FOR PREPARING CYCLIC OLEFIN-BASED OLIGOMER OR OLEFIN-BASED POLYMER BY USING SAME | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2025-06-12 | — | — | US | disclosed |
| US-20240294705-A1 | TRANSITION METAL COMPLEX CATALYST COMPOSITION FOR POLYMERIZATION OF MONOMER HAVING CYCLIC ESTER GROUP AND METHOD OF PRODUCING POLYMER USING THE SAME | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2024-09-05 | — | — | US | disclosed |
| US-20240245670-A1 | DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES | NOVARTIS AG (CH) | 2024-07-25 | — | — | US | disclosed |
| WO-2024043542-A1 | CATALYST COMPOSITION FOR CYCLIC OLEFIN POLYMERIZATION, AND METHOD FOR PREPARING CYCLIC OLEFIN-BASED OLIGOMER OR OLEFIN-BASED POLYMER BY USING SAME | 경북대학교 산학협력단 | 2024-02-29 | — | — | WO | disclosed |
| CN-104910213-B | A kind of phenylchinoline derivative iridium (III) complex substituted based on piperidines or morpholine methylene and its preparation method and application | 南京邮电大学 | 2018-05-18 | — | — | CN | disclosed |
| CN-103664876-B | Quinoline derivatives and uses thereof | SUZHOU SOUTHEAST PHARMACEUTICALS CO., LTD. (CN) | 2016-04-20 | — | — | CN | disclosed |
| CN-105218588-A | A kind of preparation method and application of pyridyl benzoglyoxaline phenylquinoline iridium (III) title complex based on Long carbon chain modification | UNIV NANJING POSTS & TELECOMM | 2016-01-06 | — | — | CN | disclosed |
| CN-104910213-A | Phenyl quinoline derivative iridium (III) complex based on piperidine or morpholine methylene substitution, and preparation method and application thereof | UNIV NANJING POSTS & TELECOMM | 2015-09-16 | — | — | CN | disclosed |
| CN-103772353-A | Quinoline and application thereof | UNIV SOUTHEAST | 2014-05-07 | — | — | CN | disclosed |
| CN-103664876-A | Quinoline derivative and usage thereof | SOUTHEAST PHARMACEUTICALS CO LTD | 2014-03-26 | — | — | CN | disclosed |
| CN-1019973-C | Piperidine derivative and pharmaceutical composition containing the same | EISAI CO LTD (JP) | 1993-03-03 | — | — | CN | disclosed |
| CN-87100928-A | Piperidine derivatives and pharmaceutical compositions thereof | — | 1987-09-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240245670-A1 | DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES | IKZF1, IKZF2, IKZF3 | FAAH 4867/4885KDM4E 345/4885ALDH1A1 2942/4885 |
| US-20240294705-A1 | TRANSITION METAL COMPLEX CATALYST COMPOSITION FOR POLYMERIZATION OF MONOMER HAVING CYCLIC ESTER GROUP AND METHOD OF PRODUCING POLYMER USING THE SAME | AP3M1, AP2M1, CAD | FAAH 2948/4885KDM4E 786/4885ALDH1A1 3522/4885 |
| US-20250186981-A1 | CATALYST COMPOSITION FOR CYCLIC OLEFIN POLYMERIZATION, AND METHOD FOR PREPARING CYCLIC OLEFIN-BASED OLIGOMER OR OLEFIN-BASED POLYMER BY USING SAME | PPOX, COG7, ODC1 | FAAH 734/4885KDM4E 4231/4885ALDH1A1 2763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.